Impact of simulated reduced injected dose on the assessment of amyloid PET scans

Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations

(2023) Emma S. Luckett et al.   NeuroImage-Clinical

Overview of tau PET molecular imaging

(2022) Gabriel Cassinelli Petersen et al.   CURRENT OPINION IN NEUROLOGY

Quantification of amyloid PET for future clinical use: a state-of-the-art review

(2022) Hugh G. Pemberton et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Imaging of Synaptic Density in Neurodegenerative Disorders

(2022) Richard E. Carson et al.   JOURNAL OF NUCLEAR MEDICINE

Patterns of Focal Amyloid Deposition Using 18F-Florbetaben PET in Patients with Cognitive Impairment

(2022) Sung-eun Chung et al.   Diagnostics

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3

(2022) Pierrick Bourgeat et al.   NEUROIMAGE

Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent

(2021) Lyduine E. Collij et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images

(2021) Marco Bucci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging

(2021) Isadora Lopes Alves et al.   Alzheimers Research & Therapy

New PET technologies – embracing progress and pushing the limits

(2021) Nicolas Aide et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data

(2021) Leonardo Iaccarino et al.   NEUROIMAGE

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study

(2020) Isadora Lopes Alves et al.   Alzheimers & Dementia

Multi-tracer model for staging cortical amyloid deposition using PET imaging

(2020) Lyduine E. Collij et al.   NEUROLOGY

[11C]PIB amyloid quantification: effect of reference region selection

(2020) Fiona Heeman et al.   EJNMMI Research

First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*

(2019) Ramsey D. Badawi et al.   JOURNAL OF NUCLEAR MEDICINE

Dose Reduction in Brain [18F]FDG PET/MRI: Give It Half a Chance

(2019) Marine Soret et al.   MOLECULAR IMAGING AND BIOLOGY

Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals

(2019) Tessa Timmers et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

(2018) Elena Prieto et al.   Physica Medica-European Journal of Medical Physics

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies

(2018) Yi Su et al.   NeuroImage-Clinical

AMYPAD Diagnostic and Patient Management Study: Rationale and design

(2018) Giovanni B. Frisoni et al.   Alzheimers & Dementia

Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

(2018) Lyduine Collij et al.   JOURNAL OF NUCLEAR MEDICINE

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods

(2018) Mark R. Battle et al.   EJNMMI Research

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

(2017) Sebastian Palmqvist et al.   Nature Communications

Recent Advances and Future Progress in PET Instrumentation

(2016) Piotr J. Slomka et al.   SEMINARS IN NUCLEAR MEDICINE

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

(2015) William E. Klunk et al.   Alzheimers & Dementia

Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

(2015) Kerstin Heurling et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition

(2014) K. Herholz et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Radiotracer Dose Reduction in Integrated PET/MR: Implications from National Electrical Manufacturers Association Phantom Studies

(2014) M. Oehmigen et al.   JOURNAL OF NUCLEAR MEDICINE

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Reproducibility of [18f]flutemetamol pet amyloid image interpretation

(2013) Z. Walker et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Medical Exposure to Radiation and Thyroid Cancer

(2011) S.J. Schonfeld et al.   CLINICAL ONCOLOGY

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

(2011) Henryk Barthel et al.   LANCET NEUROLOGY

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

(2010) Rik Vandenberghe et al.   ANNALS OF NEUROLOGY

Comparison of Bootstrap Resampling Methods for 3-D PET Imaging

(2010) C Lartizien et al.   IEEE TRANSACTIONS ON MEDICAL IMAGING

Radiation Safety With Positron Emission Tomography and Computed Tomography

(2010) Catherine E. Devine et al.   SEMINARS IN ULTRASOUND CT AND MRI

Test-retest variability studies in Alzheimer's disease and normal ageing of the new amyloid imaging agent [18F]BAY 94-9172

(2009) Christopher C. Rowe et al.   Alzheimers & Dementia

Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers

(2009) C R Muirhead et al.   BRITISH JOURNAL OF CANCER

Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

(2009) N. Nelissen et al.   JOURNAL OF NUCLEAR MEDICINE